Skip to main content

Solar plane lands in New York City

A solar-powered airplane finished crossing the United States on Saturday, landing in New York City after flying over the Statue of Liberty during its historic bid to circle the globe, the project team said.  The spindly, single-seat experimental aircraft, dubbed Solar Impulse 2, arrived at New York's John F. Kennedy International Airport at about 4 a.m. local time after it took off about five hours beforehand at Lehigh Valley International Airport in Pennsylvania, the team reported on the airplane's website.  Such a pleasure to land in New York! For the 14th time we celebrate sustainability," said the project's co-founder Andre Borschberg on Twitter after flying over the city and the Statue of Liberty during the 14th leg of the trip around the globe. The Swiss team flying the aircraft in a campaign to build support for clean energy technologies hopes eventually to complete its circumnavigation in Abu Dhabi, where the journey began in March 2015. The solar cr...

Scientists kept a pig heart alive in a baboon for more than two years


The result could boost hopes for the successful transplantation of animal organs into people, amid a shortage of human donors. Cross-species transplants provoke a powerful immune reaction, leading to rejection of the organ by the host. But a US-German team used a combination of gene modification and immune-suppressing drugs. Their work is described in the journal Nature Communications. "It is very significant because it brings us one step closer to using these organs in humans," co-author Muhammad Mohiuddin, from the National Heart, Lung and Blood Institute in Maryland, told the AFP news agency.

"Xenotransplants - organ transplants between different species - could potentially save thousands of lives each year that are lost due to a shortage of human organs for transplantation."

Dr Mohiuddin and colleagues used a previously established line of donor pigs with three genetic modifications that allowed for a degree of immune tolerance in recipient baboons. A combination of antibodies and drugs were then used to help prevent rejection of pig hearts transplanted into five baboons.The hearts did not replace those of the monkeys, but were connected to the circulatory system via two large blood vessels in the baboon abdomen. The transplanted heart beat like a normal heart, but the baboon's own heart continued the function of pumping blood - a known method in studying organ rejection.

The median (or "middle") survival time was 298 days, while the maximum survival was 945 days - just over two-and-a-half years.

This exceeded previous records by the same group of researchers of 180 and 500 days, respectively. Given their genetic proximity to humans, primates were initially thought to be the best donor candidates. But there is no large source of captive-bred apes - which take long to grow and mature, and some, like chimpanzees, are endangered. Their genetic closeness also poses a higher danger of inter-species disease transmission, as well as ethical questions.

Pigs have since emerged as better donors. Their hearts are anatomically similar to ours, they pose a lower risk in terms of disease transmission and they mature fast. The next big test will be full pig-to-baboon heart transplants, said Dr Mohiuddin.

Discussing the treatment programme to prevent rejection of the hearts in baboons, the authors of the paper wrote: "In our opinion, this regimen appears potentially safe for human application for patients suffering from end-stage organ failure who might be candidates for initial trials of xenotransplantation."

Comments